AB-2004
- Generic Name
- AB-2004
AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
Phase 2
Active, not recruiting
- Conditions
- Autism Spectrum Disorder (ASD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Axial Therapeutics, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT04895215
- Locations
- 🇺🇸
Harmonex Neuroscience Research, Dothan, Alabama, United States
🇺🇸Southwestern Autism Research and Resource Center, Phoenix, Arizona, United States
🇺🇸Cortica Westlake, Westlake Village, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath